ANAGENICS LIMITED - Announcements

0.00%

0.7¢

Market Cap $3.474M

Consumer Defensive Household & Personal Products

Anagenics Limited is an Australia-based health and beauty-tech company that operates... Anagenics Limited is an Australia-based health and beauty-tech company that operates health wellness and beauty business servicing wholesale and retail customers through omnichannel, offering premium branded products. The Company operates through its holding entity, Anagenics Limited and its main operating subsidiary company BLC Cosmetics Pty Limited (BLC) being a distributor of prestige beauty cosmetics and beauty equipment. BLC is an importer and distributor of prestige international and local skin care and wellbeing brands, namely Thalgo, Comfort Zone, Priori and other premium brands. BLC services over 1,000 spas, clinics, salons, retail stores and online in Australia, New Zealand and the Pacific Islands. The Company's brands consist of evolis and Uspa. Evolis is an anti-ageing hair care collection focused on harnessing the scientific research to give customers' thicker and healthier hair.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

AN1	Cellmid Invited to Present at Breakfast @ BIO		17/06/15	2.14MB	Share
AN1	Positive Toxicology Study Results for CAB102	PRICE SENSITIVE	15/06/15	103.32KB	Share
AN1	Cellmid Signs Agreement with Maywufa	PRICE SENSITIVE	02/06/15	84.22KB	Share
AN1	Director Appointment / Resignation		26/05/15	64.43KB	Share
AN1	Appendix 3B		19/05/15	517.31KB	Share
AN1	Cellmid Secures $1M Loan Funding	PRICE SENSITIVE	15/05/15	81.03KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/15	325.63KB	Share
AN1	Positive Clinical Results for Cellmid Hair Growth Product	PRICE SENSITIVE	15/04/15	106.11KB	Share
AN1	Cellmid Presenting at World Congress on Angiogenesis		13/04/15	92.52KB	Share
AN1	Company Secretary Appointment/Resignation		31/03/15	58.72KB	Share
AN1	Change of Director's Interest Notice		10/03/15	351.08KB	Share
AN1	NSW Broker Meets Biotech Presentation		04/03/15	639.45KB	Share
AN1	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	24/02/15	1.16MB	Share
AN1	February 2015 Newsletter		11/02/15	1.03MB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/15	282.08KB	Share
AN1	USA Patent Granted for Treatment of Heart Failure	PRICE SENSITIVE	21/01/15	88.64KB	Share
AN1	Australian Patent Granted for Use of Midkine for Hair Growth	PRICE SENSITIVE	12/01/15	97.82KB	Share
AN1	Cleansing Notice and Appendix 3B		18/12/14	198.05KB	Share
AN1	Key Midkine Antibody Patent Granted	PRICE SENSITIVE	15/12/14	75.9KB	Share
AN1	Cellmid Capital Raising	PRICE SENSITIVE	15/12/14	72.73KB	Share
AN1	Trading Halt	PRICE SENSITIVE	11/12/14	178.91KB	Share
AN1	Cellmid signs agreement with Zoetis	PRICE SENSITIVE	17/11/14	21.29KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	29/10/14	93.21KB	Share
AN1	Results of Annual General Meeting		10/10/14	23.25KB	Share
AN1	AGM Presentation by CEO		10/10/14	1.78MB	Share
AN1	Change of Director's Interest Notice		19/09/14	72.55KB	Share
AN1	Annual Report to shareholders 2014		16/09/14	3.31MB	Share
AN1	Notice of Annual General Meeting and Proxy Form		08/09/14	269.29KB	Share
AN1	Appendix 4E and Preliminary Final Report	PRICE SENSITIVE	29/08/14	406.37KB	Share
AN1	Date of Annual General Meeting		20/08/14	56.23KB	Share
AN1	Cellmid Newsletter		18/08/14	1.47MB	Share
AN1	Cleansing Notice and Appendix 3B		15/08/14	695.58KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/14	91.69KB	Share
AN1	Cellmid Granted UK Patent for Use of Midkine for Hair Growth	PRICE SENSITIVE	16/07/14	29.37KB	Share
AN1	Landmark Study- FGF5 Critical Regulator of Human Hair Growth	PRICE SENSITIVE	15/07/14	31.41KB	Share
AN1	Quest Diagnostic License Update	PRICE SENSITIVE	20/06/14	28.46KB	Share
AN1	Manufacturing Partner Appointed by Cellmid	PRICE SENSITIVE	19/06/14	29.47KB	Share
AN1	Change of Director's Interest Notice - Graeme Kaufman		02/06/14	251.78KB	Share
AN1	Notice of ceasing to be a substantial holder		20/05/14	137.31KB	Share
AN1	Key Milestone Completed, Lead Antibody Selected	PRICE SENSITIVE	07/05/14	29.62KB	Share
AN1	Significant New Findings Presented at 3rd Midkine Symposium	PRICE SENSITIVE	30/04/14	28.98KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/14	90.15KB	Share
AN1	Release of Shares from Voluntary Escrow		22/04/14	57.44KB	Share
AN1	Cellmid Signs Mk Tribody Collaboration Agreement		15/04/14	34.95KB	Share
AN1	Presentation to the Market		31/03/14	1.17MB	Share
AN1	Cellmid News		24/03/14	1.08MB	Share
AN1	Appendix 4D and Half Yearly Accounts	PRICE SENSITIVE	27/02/14	310.73KB	Share
AN1	Cleansing Notice and Appendix 3B		17/02/14	227.13KB	Share
AN1	USA RNA/DNA Patent for Surgical Adhesion Allowed	PRICE SENSITIVE	10/02/14	29.96KB	Share
AN1	Chinese Distribution Agreement Signed for Hair Loss Products	PRICE SENSITIVE	29/01/14	29.17KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/14	101.46KB	Share
AN1	Response to ASX Query		08/01/14	152.93KB	Share
AN1	Change of Director's Interest Notice - Maria Halasz		06/01/14	72.85KB	Share
AN1	Cleansing Notice and Appendix 3B		20/12/13	219.65KB	Share
AN1	Results of Completed CK3000 Diagnostic Study	PRICE SENSITIVE	18/12/13	31.88KB	Share
AN1	Capital Raising of $2 million	PRICE SENSITIVE	11/12/13	47.67KB	Share
AN1	Trading Halt	PRICE SENSITIVE	09/12/13	52.95KB	Share
AN1	Change of Director's Interest Notice - Maria Halasz		25/11/13	74.39KB	Share
AN1	Cleansing Statement		25/11/13	20.16KB	Share
AN1	Appendix 3B and Change of Interests of Substantial Holder		25/11/13	1.24MB	Share
AN1	Results of Meeting		22/11/13	78.5KB	Share
AN1	AGM PRESENTATION BY CEO		22/11/13	1.13MB	Share
AN1	Change in substantial holding		20/11/13	139.21KB	Share
AN1	Proposed Issue of Shares		18/11/13	20.47KB	Share
AN1	Release of Shares from Voluntary Escrow		30/10/13	20.82KB	Share
AN1	Cellmid News		23/10/13	706.78KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	23/10/13	91.23KB	Share
AN1	Notice of Annual General Meeting and Proxy Form		21/10/13	142.6KB	Share
AN1	Annual Report		21/10/13	3.12MB	Share
AN1	Key Antibody Patent Granted in Japan	PRICE SENSITIVE	18/10/13	316.4KB	Share
AN1	Key European Patent for Anti-Midkine Antibodies Granted	PRICE SENSITIVE	08/10/13	28.08KB	Share
AN1	R&D Tax Refund Received	PRICE SENSITIVE	04/10/13	21.09KB	Share
AN1	Midkine antibodies effective in cancer	PRICE SENSITIVE	03/10/13	28.4KB	Share
AN1	Ceasing to be a substantial holder		27/09/13	33.21KB	Share
AN1	Cellmid Signs Major Japanese Distribution Agreement	PRICE SENSITIVE	20/09/13	23.07KB	Share
AN1	Independent Valuation Report of Advangen Inc. Japan		19/09/13	715.28KB	Share
AN1	Cellmid CEO Presents at Brokers Meets Biotech		18/09/13	1.3MB	Share
AN1	Date of Annual General Meeting		10/09/13	19.07KB	Share
AN1	Change in substantial holding		03/09/13	141.14KB	Share
AN1	Appendix 4E and Preliminary Final Report	PRICE SENSITIVE	28/08/13	679.73KB	Share
AN1	Cellmid Received Pacific Edge Milestone Shares	PRICE SENSITIVE	01/08/13	28.81KB	Share
AN1	Cellmid Collaborates on Early Diagnosis of Colorectal Cancer	PRICE SENSITIVE	29/07/13	28.92KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	26/07/13	101.33KB	Share
AN1	Release of Shares from Voluntary Escrow		22/07/13	17.45KB	Share
AN1	Fujikura Exercises Option To License Cellmid Diagnostics	PRICE SENSITIVE	18/07/13	28.66KB	Share
AN1	Appointment of Company Secretary		16/07/13	18.97KB	Share
AN1	Change of Director's Interest Notice		04/07/13	73KB	Share
AN1	Change of Director's Interest Notice		12/06/13	96.81KB	Share
AN1	Settlement of Advangen Inc. Acquisiton Completed - Form 603		28/05/13	87.43KB	Share
AN1	Cellmid Newsletter		20/05/13	787.76KB	Share
AN1	Appendix 3B		17/05/13	229.38KB	Share
AN1	CEO Presentation		08/05/13	900.66KB	Share
AN1	Advangen Acquisition	PRICE SENSITIVE	08/05/13	33.77KB	Share
AN1	Trading Halt	PRICE SENSITIVE	06/05/13	58.72KB	Share
AN1	Change of Company Address		30/04/13	19.31KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	22/04/13	96.39KB	Share
AN1	Resignation of Company Secretary		08/04/13	19.4KB	Share
AN1	Cellmid Diagnostic Licenses Update	PRICE SENSITIVE	26/03/13	32.65KB	Share
AN1	Appendix 3B		22/03/13	213.81KB	Share
AN1	Cleansing Statement		13/03/13	31.84KB	Share

AN1 Cellmid Invited to Present at Breakfast @ BIO
17/06/15		2.14MB	Share
AN1 Positive Toxicology Study Results for CAB102
15/06/15	PRICE SENSITIVE	103.32KB	Share
AN1 Cellmid Signs Agreement with Maywufa
02/06/15	PRICE SENSITIVE	84.22KB	Share
AN1 Director Appointment / Resignation
26/05/15		64.43KB	Share
AN1 Appendix 3B
19/05/15		517.31KB	Share
AN1 Cellmid Secures $1M Loan Funding
15/05/15	PRICE SENSITIVE	81.03KB	Share
AN1 Appendix 4C - quarterly
29/04/15	PRICE SENSITIVE	325.63KB	Share
AN1 Positive Clinical Results for Cellmid Hair Growth Product
15/04/15	PRICE SENSITIVE	106.11KB	Share
AN1 Cellmid Presenting at World Congress on Angiogenesis
13/04/15		92.52KB	Share
AN1 Company Secretary Appointment/Resignation
31/03/15		58.72KB	Share
AN1 Change of Director's Interest Notice
10/03/15		351.08KB	Share
AN1 NSW Broker Meets Biotech Presentation
04/03/15		639.45KB	Share
AN1 Appendix 4D and Half Year Accounts
24/02/15	PRICE SENSITIVE	1.16MB	Share
AN1 February 2015 Newsletter
11/02/15		1.03MB	Share
AN1 Appendix 4C - quarterly
28/01/15	PRICE SENSITIVE	282.08KB	Share
AN1 USA Patent Granted for Treatment of Heart Failure
21/01/15	PRICE SENSITIVE	88.64KB	Share
AN1 Australian Patent Granted for Use of Midkine for Hair Growth
12/01/15	PRICE SENSITIVE	97.82KB	Share
AN1 Cleansing Notice and Appendix 3B
18/12/14		198.05KB	Share
AN1 Key Midkine Antibody Patent Granted
15/12/14	PRICE SENSITIVE	75.9KB	Share
AN1 Cellmid Capital Raising
15/12/14	PRICE SENSITIVE	72.73KB	Share
AN1 Trading Halt
11/12/14	PRICE SENSITIVE	178.91KB	Share
AN1 Cellmid signs agreement with Zoetis
17/11/14	PRICE SENSITIVE	21.29KB	Share
AN1 Appendix 4C - quarterly
29/10/14	PRICE SENSITIVE	93.21KB	Share
AN1 Results of Annual General Meeting
10/10/14		23.25KB	Share
AN1 AGM Presentation by CEO
10/10/14		1.78MB	Share
AN1 Change of Director's Interest Notice
19/09/14		72.55KB	Share
AN1 Annual Report to shareholders 2014
16/09/14		3.31MB	Share
AN1 Notice of Annual General Meeting and Proxy Form
08/09/14		269.29KB	Share
AN1 Appendix 4E and Preliminary Final Report
29/08/14	PRICE SENSITIVE	406.37KB	Share
AN1 Date of Annual General Meeting
20/08/14		56.23KB	Share
AN1 Cellmid Newsletter
18/08/14		1.47MB	Share
AN1 Cleansing Notice and Appendix 3B
15/08/14		695.58KB	Share
AN1 Appendix 4C - quarterly
29/07/14	PRICE SENSITIVE	91.69KB	Share
AN1 Cellmid Granted UK Patent for Use of Midkine for Hair Growth
16/07/14	PRICE SENSITIVE	29.37KB	Share
AN1 Landmark Study- FGF5 Critical Regulator of Human Hair Growth
15/07/14	PRICE SENSITIVE	31.41KB	Share
AN1 Quest Diagnostic License Update
20/06/14	PRICE SENSITIVE	28.46KB	Share
AN1 Manufacturing Partner Appointed by Cellmid
19/06/14	PRICE SENSITIVE	29.47KB	Share
AN1Change of Director's Interest Notice - Graeme Kaufman
02/06/14		251.78KB	Share
AN1Notice of ceasing to be a substantial holder
20/05/14		137.31KB	Share
AN1Key Milestone Completed, Lead Antibody Selected
07/05/14	PRICE SENSITIVE	29.62KB	Share
AN1Significant New Findings Presented at 3rd Midkine Symposium
30/04/14	PRICE SENSITIVE	28.98KB	Share
AN1Appendix 4C - quarterly
28/04/14	PRICE SENSITIVE	90.15KB	Share
AN1Release of Shares from Voluntary Escrow
22/04/14		57.44KB	Share
AN1Cellmid Signs Mk Tribody Collaboration Agreement
15/04/14		34.95KB	Share
AN1Presentation to the Market
31/03/14		1.17MB	Share
AN1Cellmid News
24/03/14		1.08MB	Share
AN1Appendix 4D and Half Yearly Accounts
27/02/14	PRICE SENSITIVE	310.73KB	Share
AN1Cleansing Notice and Appendix 3B
17/02/14		227.13KB	Share
AN1USA RNA/DNA Patent for Surgical Adhesion Allowed
10/02/14	PRICE SENSITIVE	29.96KB	Share
AN1Chinese Distribution Agreement Signed for Hair Loss Products
29/01/14	PRICE SENSITIVE	29.17KB	Share
AN1Appendix 4C - quarterly
28/01/14	PRICE SENSITIVE	101.46KB	Share
AN1Response to ASX Query
08/01/14		152.93KB	Share
AN1Change of Director's Interest Notice - Maria Halasz
06/01/14		72.85KB	Share
AN1Cleansing Notice and Appendix 3B
20/12/13		219.65KB	Share
AN1Results of Completed CK3000 Diagnostic Study
18/12/13	PRICE SENSITIVE	31.88KB	Share
AN1Capital Raising of $2 million
11/12/13	PRICE SENSITIVE	47.67KB	Share
AN1Trading Halt
09/12/13	PRICE SENSITIVE	52.95KB	Share
AN1Change of Director's Interest Notice - Maria Halasz
25/11/13		74.39KB	Share
AN1Cleansing Statement
25/11/13		20.16KB	Share
AN1Appendix 3B and Change of Interests of Substantial Holder
25/11/13		1.24MB	Share
AN1Results of Meeting
22/11/13		78.5KB	Share
AN1AGM PRESENTATION BY CEO
22/11/13		1.13MB	Share
AN1Change in substantial holding
20/11/13		139.21KB	Share
AN1Proposed Issue of Shares
18/11/13		20.47KB	Share
AN1Release of Shares from Voluntary Escrow
30/10/13		20.82KB	Share
AN1Cellmid News
23/10/13		706.78KB	Share
AN1Appendix 4C - quarterly
23/10/13	PRICE SENSITIVE	91.23KB	Share
AN1Notice of Annual General Meeting and Proxy Form
21/10/13		142.6KB	Share
AN1Annual Report
21/10/13		3.12MB	Share
AN1Key Antibody Patent Granted in Japan
18/10/13	PRICE SENSITIVE	316.4KB	Share
AN1Key European Patent for Anti-Midkine Antibodies Granted
08/10/13	PRICE SENSITIVE	28.08KB	Share
AN1R&D Tax Refund Received
04/10/13	PRICE SENSITIVE	21.09KB	Share
AN1Midkine antibodies effective in cancer
03/10/13	PRICE SENSITIVE	28.4KB	Share
AN1Ceasing to be a substantial holder
27/09/13		33.21KB	Share
AN1Cellmid Signs Major Japanese Distribution Agreement
20/09/13	PRICE SENSITIVE	23.07KB	Share
AN1Independent Valuation Report of Advangen Inc. Japan
19/09/13		715.28KB	Share
AN1Cellmid CEO Presents at Brokers Meets Biotech
18/09/13		1.3MB	Share
AN1Date of Annual General Meeting
10/09/13		19.07KB	Share
AN1Change in substantial holding
03/09/13		141.14KB	Share
AN1Appendix 4E and Preliminary Final Report
28/08/13	PRICE SENSITIVE	679.73KB	Share
AN1Cellmid Received Pacific Edge Milestone Shares
01/08/13	PRICE SENSITIVE	28.81KB	Share
AN1Cellmid Collaborates on Early Diagnosis of Colorectal Cancer
29/07/13	PRICE SENSITIVE	28.92KB	Share
AN1Appendix 4C - quarterly
26/07/13	PRICE SENSITIVE	101.33KB	Share
AN1Release of Shares from Voluntary Escrow
22/07/13		17.45KB	Share
AN1Fujikura Exercises Option To License Cellmid Diagnostics
18/07/13	PRICE SENSITIVE	28.66KB	Share
AN1Appointment of Company Secretary
16/07/13		18.97KB	Share
AN1Change of Director's Interest Notice
04/07/13		73KB	Share
AN1Change of Director's Interest Notice
12/06/13		96.81KB	Share
AN1Settlement of Advangen Inc. Acquisiton Completed - Form 603
28/05/13		87.43KB	Share
AN1Cellmid Newsletter
20/05/13		787.76KB	Share
AN1Appendix 3B
17/05/13		229.38KB	Share
AN1CEO Presentation
08/05/13		900.66KB	Share
AN1Advangen Acquisition
08/05/13	PRICE SENSITIVE	33.77KB	Share
AN1Trading Halt
06/05/13	PRICE SENSITIVE	58.72KB	Share
AN1Change of Company Address
30/04/13		19.31KB	Share
AN1Appendix 4C - quarterly
22/04/13	PRICE SENSITIVE	96.39KB	Share
AN1Resignation of Company Secretary
08/04/13		19.4KB	Share
AN1Cellmid Diagnostic Licenses Update
26/03/13	PRICE SENSITIVE	32.65KB	Share
AN1Appendix 3B
22/03/13		213.81KB	Share
AN1Cleansing Statement
13/03/13		31.84KB	Share

REFRESH

First 4 5 6 7 8

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.7¢		Change 0.000(0.00%)		Mkt cap ! $3.474M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
2	1544100	0.6¢

Sellers (Offers)

Price($)	Vol.	No.
0.7¢	364754	3

View Market Depth

No.	Vol.	Price($)
2	1544100	0.006
1	750000	0.005
6	7665000	0.004
3	5450000	0.003
1	800000	0.002

Price($)	Vol.	No.
0.007	364754	3
0.008	653713	2
0.009	620000	2
0.010	500000	1
0.015	200000	1

Last trade - 16.21pm 08/08/2025 (20 minute delay)

AN1 (ASX) Chart

Day chart unavailable

ANAGENICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available